Patent · US Active

Heterocyclic compounds

US7645758B2 · kind B2 · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 13, 2007
Grant dateJan 12, 2010
Priority date
Expiry dateAug 2, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain thienopyrrolyl and furanopyrrolyl compounds are disclosed as useful to treat or prevent disorders and conditions mediated by the histamine H4 receptor, including allergic rhinitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.